This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
5 Industrial Production Stocks to Buy on Solid Data for May
by Nalak Das
We have narrowed down our search to five industrial product stocks that have strong growth potential for the rest of 2021. These are: DE, CAT, PH, EMR and XYL.
Zacks.com featured highlights include: Xylem, Callon Petroleum, United Rentals, Blackstone Group and Atlas Air
by Zacks Equity Research
Zacks.com featured highlights include: Xylem, Callon Petroleum, United Rentals, Blackstone Group and Atlas Air
5 Top Stocks With Robust Sales Growth Worth Buying Right Now
by Swayta Shah
Sales growth is a key indicator of a company's health and ability to sustain its business. Let's check Xylem (XYL), Callon Petroleum (CPE), United Rentals (URI), Blackstone (BX) and Atlas Air Worldwide (AAWW) as these are likely to record strong sales growth.
Reasons Why it is Worth Investing in Xylem (XYL) Stock Now
by Zacks Equity Research
Xylem (XYL) to benefit from solid demand in multiple end-markets, healthy backlog, cost measures and innovation capabilities. Also, its shareholder-friendly policies bode well.
Are You Looking for a Top Momentum Pick? Why Xylem (XYL) is a Great Choice
by Zacks Equity Research
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem (XYL) Up 1.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Deere, Caterpillar, Xylem, Parker-Hannifin and Illinois Tool Works
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deere, Caterpillar, Xylem, Parker-Hannifin and Illinois Tool Works
U.S. Manufacturing Thriving Amid Supply Bottleneck: 5 Picks
by Nalak Das
We have narrowed down our search to five manufacturing stocks with strong growth potential for 2021. These are CAT, DE, PH, ITW and XYL.
Xylem (XYL) Is Up 7.85% in One Week: What You Should Know
by Zacks Equity Research
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 Stocks to Outshine the Thriving Industrial Manufacturing Industry
by Zacks Equity Research
The Zacks Manufacturing - General Industrial industry seems to be gaining from rise in economic activities, higher orders and technological advancement in manufacturing processes. Four stocks, ITW, PH, XYL and GGG, are the likely outperformers from the industry.
Company News for May 5, 2021
by Zacks Equity Research
Companies In The News Are: VMC, XYL, BEN, AME.
Xylem (XYL) Beats on Q1 Earnings, Increases '21 Projections
by Zacks Equity Research
Xylem's (XYL) Q1 earnings increase year over year on improved sales and margin performance. Anticipating healthy demand, it hikes projections for 2021.
Xylem (XYL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 51.35% and 7.11%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem (XYL) Q1 results are likely to reflect the pandemic-led uncertainties, and cost-inflation and investment woes. Contract wins, diversified businesses and cost actions are likely to have aided.
Xylem (XYL) Gains From Solid Demand Amid Cost Inflation Woes
by Zacks Equity Research
Xylem's (XYL) diversified business, solid product offerings, shareholder-friendly policies and solid contract wins are beneficial. Cost inflation and high debts might be worrisome.
Xylem (XYL) Beats Q4 Earnings Estimates, Gives Impressive View
by Zacks Equity Research
Xylem's (XYL) Q4 earnings decline year over year due to weakness in organic sales and margins. For 2021, earnings and sales are anticipated to increase year over year.
Xylem (XYL) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 17.39% and 6.03%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Xylem (XYL) Q4 results are likely to reflect the pandemic's impacts, high costs of sales and huge investments. Product offerings, contract wins and cost-control actions are anticipated to have aided.
Pentair (PNR) Hikes Dividend, Okays New Share Buyback Program
by Zacks Equity Research
Pentair's (PNR) latest dividend hike of 5% and new share repurchase authorization reflect its solid cash position.
Xylem (XYL) Q3 Earnings Top Estimates, Q4 Organic View Weak
by Zacks Equity Research
Xylem's (XYL) Q3 earnings beat estimates, while falling year over year due to weak sales generation and a decline in margins. Organic sales in the fourth quarter are predicted to fall year over year.
Xylem (XYL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 19.23% and 4.47%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks' Earnings Due This Week: AOS, XYL, MHVYF
by Avisekh Bhattacharjee
The market downturn due to pandemic-related issues, lower production and other headwinds are expected to have affected earnings of the majority of industrial stocks in the July-September quarter. Let's see how AOS, XYL, MHVYF are likely to have fared.
Xylem (XYL) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem's (XYL) Q3 results are likely to reflect the adverse impacts of the pandemic on operations. Product offerings, impressive backlog and savings from cost actions are expected to have aided.
FLS vs. XYL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FLS vs. XYL: Which Stock Is the Better Value Option?
Xylem (XYL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.